Search Results

Site Search

Next-generation sequencing - Insights

Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.

Advanced Crohn's monitoring test launched by Mayo Clinic - Insights

Mayo Clinic Laboratories introduces an advancement in the management of Crohn's disease with the release of a new laboratory test that measures Risankizumab levels in patients. This test will advance the therapeutic monitoring of Crohn's...

Looking Back on Clinical Chemistry 1 - Insights

Kylie Reising, a student in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course.

Study can improve understanding of how disability develops in MS - Insights

Mayo Clinic researchers have identified clear differences in brain and spinal cord scarring in patients with demyelinating diseases.

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score - Insights

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score.

Industry Archives - Page 6 of 6 - Insights

Skip to Content MayoACCESS MayoLINK...

Bobbi Pritt, M.D., Discusses Hookworms with The Washington Post - Insights

The Washington Post recently reported on hookworms burrowing into a teenager's skin during a trip to Florida. Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services at Mayo Clinic,...

CPT codes and LOINC update: March 2024 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of March.

Mayo Clinic Laboratory and Pathology Research Roundup: May 21 - Insights

This week's research roundup feature: Monoclonal immunoglobulin (MIg) crystalline nephropathies are rare lesions resulting from precipitation of MIgs in the kidney as crystalline inclusions. They can be categorized into lesions with...

Innovative Alzheimer's disease diagnostic tool unveiled - Insights

Mayo Clinic Laboratories has marked a significant advancement in the fight against Alzheimer's disease with the introduction of an innovative diagnostic test. This noninvasive blood test accurately detects the p-Tau217 biomarker, indicative...